GotoPER - Physicians' Education Resource
Video

Module 2: Keynote: Evidence for MRD as a Biomarker Across Hematologic Malignancies

Create AccountAlready Registered? Login Here

Release Date

August 17, 2026

Expiration Date

August 18, 2027

Credits

0.75 CME, NCPD

Activity Overview

This educational activity is an archive of the live conference held on July 11 – 12, 2026.

Target Audience

This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.

Learning Objectives

  • Evaluate the efficacy and safety of approved and emerging therapies based on current clinical trial data
        Module 2: Keynote: Evidence for MRD as a Biomarker Across Hematologic Malignancies

        GET STARTED WITH THIS PROGRAM:

        Register now to gain access to this program.

        Create AccountAlready Registered? Login Here

        Click Here to return to Learning Hub

        Accreditation/Credit Designation

        Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

        Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 0.75 Contact Hours.

        Acknowledgment of Commercial Support

        This activity is supported by educational grants from AstraZeneca Pharmaceuticals; Janssen Scientific Affairs, LLC; and Lilly.

        Follow Us on Social Media!

        You Also Might Like...

        Course

        Module 2: Keynote: Evidence for MRD as a Biomarker Across Hematologic Malignancies

        Create Account